HIV Point-of-care Testing Market, Global Outlook and Forecast 2024-2030
The global HIV Point-of-care Testing market size was valued at US$ 1.23 billion in 2024 and is projected to reach US$ 2.15 billion by 2030, at a CAGR of 9.8% during the forecast period 2024-2030.
The United States HIV Point-of-care Testing market size was valued at US$ 345.6 million in 2024 and is projected to reach US$ 578.9 million by 2030, at a CAGR of 9.0% during the forecast period 2024-2030.
HIV Point-of-care Testing provides rapid diagnostic results for HIV infection at the testing location, enabling immediate clinical decisions and treatment initiation.
The global market is growing rapidly, driven by public health initiatives and early diagnosis emphasis. In 2023, test volume reached 250 million globally, with healthcare facilities accounting for 55% of demand. The market saw a 40% increase in molecular POC test adoption in 2023. Rapid antibody tests dominate with a 65% market share, while molecular tests are growing at 15% annually. Africa leads with a 40% market share, while Asia Pacific is the fastest-growing region at 11.2% CAGR. The industry is focusing on developing integrated digital solutions, with a 45% growth in R&D investments for result management.
Report Overview
HIV Point-of-care Testing is used to screen HIV antibodies. They can be performed in hospitals, clinics, and home care settings, and the results of these tests are available within a few minutes.
This report provides a deep insight into the global HIV Point-of-care Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global HIV Point-of-care Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the HIV Point-of-care Testing market in any manner.
Global HIV Point-of-care Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott
BD
Biomerieux
Adaltis
Roche
Market Segmentation (by Type)
Testing Equipment
Testing Reagent
Market Segmentation (by Application)
Hospitals
Clinics
Home Care Setting
Geographic Segmentation
